- Status:
- Do Not Prescribe (DNP), Red
- Decision Date:
- September 2019
Comments
RED:
- NICE TA592: for treating metastatic or locally advanced cutaneous squamous cell carcinoma. (NHSE commissioned). (Decision date - September 2019).
- NICE TA802: for treating advanced cutaneous squamous cell
carcinoma. (NHSE commissioned). (Decision date - July 2022).
DNP:
- NICE TA848: for untreated PD-L1-positive advanced or metastatic non-small-cell lung cancer (terminated appraisal) (Decision date - January 2023)
- NICE TA901 - Cemiplimab for treating recurrent or metastatic cervical cancer (Terminated appraisal) (Decision date - July 2023)
Red Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again